Metraipolis › archive › dc_89b9de5b97fa
Artificial Intelligence-Driven Nanomedicine: From Drug Formulation and Nanocarrier Design to Clinical Translation — Europe PMC PMID:42514923
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42514923
- DOI
- 10.3390/pharmaceutics18070845
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T02:42:44.484Z
- SHA-256 of the archived text
13eb4d157d45afa88fd375c0abeea127cdce36599f681ac62f7cdbd483b6dce8- Stable URL of this page
https://metraipolis.com/documento/dc_89b9de5b97fa
How to cite
Artificial Intelligence-Driven Nanomedicine: From Drug Formulation and Nanocarrier Design to Clinical Translation — Europe PMC PMID:42514923 — Europe PMC (en), https://europepmc.org/article/MED/42514923 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_89b9de5b97fa (Metraipolis archive dc_89b9de5b97fa, sha256 13eb4d157d45afa88fd375c0abeea127cdce36599f681ac62f7cdbd483b6dce8)
BibTeX
@misc{dc89b9de5b97fa,
title = {Artificial Intelligence-Driven Nanomedicine: From Drug Formulation and Nanocarrier Design to Clinical Translation — Europe PMC PMID:42514923},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42514923},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_89b9de5b97fa; sha256 13eb4d157d45afa88fd375c0abeea127cdce36599f681ac62f7cdbd483b6dce8},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42514923. Agents can read the archived copy with the MCP tool read_document.